[Hiring] VP, Novel Asset Advancement @AMER

Role Description

The VP, Novel Asset Advancement will serve as the executive asset owner for Telix’s CD66-targeted hematology-oncology programs, with accountability for the end-to-end strategy, advancement, and value realization of TLX66 diagnostic and therapeutic candidates through clinical development and toward registration. This role is critical to advancing Telix’s first hematology-oncology product and directly impacts pipeline value, portfolio strategy, and long-term company growth.

Key Accountabilities

• Serve as the executive asset owner for Telix’s CD66-targeted hematology-oncology programs, with full accountability for end-to-end asset strategy, progression, and value realization through clinical development and toward registration.
• Define and continuously evolve the integrated asset strategy, including development approach, indication prioritization, target product profile, and long-range positioning aligned to enterprise portfolio priorities.
• Own the integrated business case, including financial assumptions, risk-adjusted scenarios, and value inflection points, and lead executive-level recommendations on investment, prioritization, and development pathways.
• Act as the primary accountable leader in executive governance forums (e.g., GET), presenting strategic options, trade-offs, and recommendations while driving enterprise decision-making and alignment.
• Operate as a peer to functional Vice Presidents, leading cross-functional alignment across Clinical, Regulatory, Manufacturing, Commercial, Finance, and Quality to ensure execution of a unified and optimized development strategy.
• Drive enterprise-level trade-off decisions, balancing scientific, clinical, regulatory, operational, and financial considerations to maximize probability of success and long-term asset value.
• Maintain accountability for program performance, including milestone achievement, risk profile, timeline integrity, and overall readiness for key development and regulatory inflection points.
• Lead identification, evaluation, and mitigation of strategic and operational risks, ensuring proactive management and clear escalation of critical issues to executive leadership.
• Provide strategic financial oversight of the program, including investment planning, scenario modeling, and alignment of resource allocation with development priorities and enterprise objectives.
• Ensure consistent executive-level visibility into program status, risks, opportunities, and strategic options through structured governance and performance reviews.
• Influence broader portfolio strategy and lifecycle planning, including evaluation of expansion opportunities and implications for future hematology-oncology pipeline development.
• Drive a high-performance cross-functional operating model, holding stakeholders accountable for delivering against shared objectives while enabling speed, clarity, and disciplined decision-making.

Qualifications

• Advanced degree in life sciences, medicine, pharmacy, or related field required; PhD, MD, or PharmD preferred.
• 15+ years of progressive pharmaceutical or biotechnology experience, including significant experience in drug development and strategic program or asset leadership.
• Demonstrated experience leading complex, cross-functional development programs or assets, ideally within oncology.
• Proven ability to own and advance asset strategy, including business case development, development planning, and governance engagement.
• Strong understanding of global regulatory environments (FDA, EMA, APAC) and their impact on development strategy.
• Demonstrated success operating as a senior individual contributor influencing executive leadership and cross-functional decision-making.
• Experience presenting to and influencing executive governance bodies (e.g., executive committees, portfolio boards).
• Strong financial and strategic acumen, including investment decision support, scenario planning, and risk management.

Key Capabilities

• Inclusive mindset: Demonstrate an understanding and appreciation for diversity, and actively work to create an inclusive environment where everyone feels valued and respected.
• Creativity and innovation: Possess a willingness to think outside the box and come up with unique and creative solutions to challenges.
• Commitment to excellence: Take pride in your work and consistently strive for excellence in everything you do.
• Results-oriented: Driven to achieve goals and objectives, with a strong focus on delivering measurable results.
• Ethical behavior: Act with integrity and demonstrate a commitment to ethical behavior in all interactions with colleagues and stakeholders.
• Adaptability: Comfortable working in a dynamic environment, able to adjust to changing priorities, and willing to take on new challenges.
• Strong communication skills: Able to communicate effectively with colleagues and stakeholders at all levels, using clear and concise language.
• Collaboration: Work effectively as part of a team, actively sharing knowledge and expertise to achieve common goals.
• Resilience: Demonstrate the ability to bounce back from setbacks and persevere in the face of challenges.
• Continuous learning: Show a commitment to ongoing learning and professional development, continually seeking out opportunities to expand your knowledge and skills.